‘It is okay not to be okay’: NFL legend Terrell Davis joins growing roster of athletes partnering with big pharma to raise health awareness

**Terrell Davis Partners with Teva Pharmaceuticals to Raise Awareness for Tardive Dyskinesia**

Former Denver Broncos running back Terrell Davis has joined a growing roster of athletes partnering with big pharma to raise health awareness, lending his voice to a campaign that aims to educate patients about Tardive Dyskinesia, a debilitating neurological movement disorder.

Background & Context

The pharmaceutical industry has long relied on television commercials to promote branded medication, but in recent years, companies have begun investing in a different kind of marketing strategy – one that leverages the credibility and influence of professional athletes who have publicly discussed their own health struggles.

This shift reflects a growing recognition within the industry of the value of athlete endorsements, particularly when it comes to raising awareness for underdiagnosed conditions. By partnering with trusted athletes, drugmakers can tap into the public's trust and familiarity with these individuals, making their message more relatable and effective.

Key Details

As part of his partnership with Teva Pharmaceuticals, Davis is participating in a campaign called "The Other TD," which aims to raise awareness for Tardive Dyskinesia, a condition characterized by involuntary movements and muscle contractions that can be a side effect of certain medications used to treat mental health conditions.

"I was prescribed medication as part of my mental health treatment – though not one linked to TD – which is what made Lori's diagnosis feel personal rather than abstract," Davis said in a statement. "That could have been me. I may have been on medication and could have gotten TD."

Davis' involvement with the program is personal, as he has experienced mental health challenges in the years following his football career. He credits the campaign with helping him understand the importance of raising awareness for underdiagnosed conditions like Tardive Dyskinesia.

Austedo, one of the leading prescription treatments approved for Tardive Dyskinesia, is manufactured by Teva and is a significant revenue driver for the company as it faces generic competition on older drugs.

What Experts Say

According to Dr. Paul Summergrad, a psychiatrist and professor at Tufts University School of Medicine, the use of athlete endorsements in pharmaceutical marketing represents a significant shift in the industry's approach to patient education.

"Athletes have a unique ability to connect with the public on a personal level, and when they share their own experiences with mental health or neurological conditions, it can have a profound impact on people's perceptions and behaviors," Dr. Summergrad said.

Dr. Summergrad notes that this approach is particularly effective when it comes to raising awareness for underdiagnosed conditions like Tardive Dyskinesia, which can be a side effect of certain medications used to treat mental health conditions.

Key Takeaways

• Terrell Davis has partnered with Teva Pharmaceuticals to raise awareness for Tardive Dyskinesia, a debilitating neurological movement disorder.
• The campaign, called "The Other TD," aims to educate patients about the condition and encourage them to discuss symptoms with healthcare providers.
• Austedo, a leading prescription treatment for Tardive Dyskinesia, is manufactured by Teva and is a significant revenue driver for the company.
• Dr. Paul Summergrad, a psychiatrist and professor at Tufts University School of Medicine, notes that athlete endorsements can have a profound impact on people's perceptions and behaviors when it comes to mental health and neurological conditions.

What This Means For You

The partnership between Davis and Teva Pharmaceuticals serves as a reminder that mental health and neurological conditions are often underdiagnosed and undertreated.

By sharing his personal story and lending his voice to the campaign, Davis is helping to raise awareness for Tardive Dyskinesia and encouraging patients to discuss symptoms with their healthcare providers.

For everyday readers, this means being more aware of the potential side effects of medication and being proactive in discussing symptoms with their healthcare providers.

As Davis himself has said, "It's okay not to be okay." By sharing his story and partnering with Teva Pharmaceuticals, Davis is helping to break down the stigma surrounding mental health and neurological conditions, and encouraging others to do the same.